- $1.89bn
- $1.46bn
- $1.36bn
- 93
- 91
- 72
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 944 | 886 | 542 | 1,063 | 1,364 |
Cost of Revenue | |||||
Gross Profit | 290 | 369 | 48.1 | 390 | 670 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 820 | 745 | 736 | 807 | 829 |
Operating Profit | 124 | 142 | -194 | 256 | 536 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 61.5 | 94.6 | -244 | 230 | 523 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.4 | 87.3 | -242 | 229 | 514 |
Net Income Before Extraordinary Items | |||||
Net Income | 41.4 | 87.3 | -242 | 229 | 514 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 41.4 | 87.3 | -242 | 229 | 514 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.34 | 4.53 | -5.39 | 6.48 | 14.6 |
Dividends per Share | |||||
Special Dividends per Share |